Annual SG&A
$37.02 M
+$20.90 M+129.64%
31 December 2023
Summary:
Viking Therapeutics annual selling, general & administrative expenses is currently $37.02 million, with the most recent change of +$20.90 million (+129.64%) on 31 December 2023. During the last 3 years, it has risen by +$26.29 million (+244.99%). VKTX annual SG&A is now at all-time high.VKTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$13.77 M
+$3.49 M+33.89%
30 September 2024
Summary:
Viking Therapeutics quarterly selling, general & administrative expenses is currently $13.77 million, with the most recent change of +$3.49 million (+33.89%) on 30 September 2024. Over the past year, it has increased by +$4.88 million (+54.97%). VKTX quarterly SG&A is now at all-time high.VKTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.66 B
-$99.15 M-6.34%
30 September 2024
Summary:
Viking Therapeutics TTM selling, general & administrative expenses is currently -$1.66 billion, with the most recent change of -$99.15 million (-6.34%) on 30 September 2024. Over the past year, it has dropped by -$1.70 billion (-5242.64%). VKTX TTM SG&A is now -341998.52% below its all-time high of $42.81 million, reached on 30 September 2024.VKTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VKTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +129.6% | +55.0% | -5242.6% |
| 3 y3 years | +245.0% | +428.0% | -10000.0% |
| 5 y5 years | +419.9% | +537.5% | -10000.0% |
VKTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +246.0% | at high | +428.0% | -119.2% | at low |
| 5 y | 5 years | at high | +419.9% | at high | +537.5% | -271.7% | at low |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | <-9999.0% | at low |
Viking Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $13.77 M(+33.9%) | $42.81 M(+12.9%) |
| June 2024 | - | $10.29 M(+3.2%) | $37.92 M(+1.2%) |
| Mar 2024 | - | $9.97 M(+13.5%) | $37.46 M(+1.2%) |
| Dec 2023 | $37.02 M(+129.6%) | $8.78 M(-1.2%) | $37.02 M(+14.5%) |
| Sept 2023 | - | $8.89 M(-9.5%) | $32.34 M(+16.8%) |
| June 2023 | - | $9.82 M(+3.1%) | $27.69 M(+26.1%) |
| Mar 2023 | - | $9.53 M(+132.1%) | $21.96 M(+36.2%) |
| Dec 2022 | $16.12 M(+50.6%) | $4.11 M(-3.1%) | $16.12 M(+9.8%) |
| Sept 2022 | - | $4.24 M(+3.6%) | $14.68 M(+12.5%) |
| June 2022 | - | $4.09 M(+10.8%) | $13.05 M(+11.6%) |
| Mar 2022 | - | $3.69 M(+38.6%) | $11.70 M(+9.3%) |
| Dec 2021 | $10.70 M(-0.3%) | $2.66 M(+2.1%) | $10.70 M(+4.3%) |
| Sept 2021 | - | $2.61 M(-4.7%) | $10.26 M(-1.1%) |
| June 2021 | - | $2.74 M(+1.6%) | $10.37 M(-0.9%) |
| Mar 2021 | - | $2.69 M(+21.5%) | $10.46 M(-2.5%) |
| Dec 2020 | $10.73 M(+17.6%) | $2.22 M(-18.7%) | $10.73 M(-1.9%) |
| Sept 2020 | - | $2.73 M(-3.5%) | $10.94 M(+5.5%) |
| June 2020 | - | $2.83 M(-4.6%) | $10.37 M(+6.0%) |
| Mar 2020 | - | $2.96 M(+22.3%) | $9.78 M(+7.1%) |
| Dec 2019 | $9.13 M(+28.2%) | $2.42 M(+12.1%) | $9.13 M(+5.5%) |
| Sept 2019 | - | $2.16 M(-3.4%) | $8.65 M(+5.5%) |
| June 2019 | - | $2.24 M(-3.2%) | $8.20 M(+6.9%) |
| Mar 2019 | - | $2.31 M(+18.6%) | $7.67 M(+7.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $7.12 M(+33.6%) | $1.95 M(+14.1%) | $7.12 M(+8.4%) |
| Sept 2018 | - | $1.71 M(+0.2%) | $6.57 M(+7.9%) |
| June 2018 | - | $1.70 M(-3.3%) | $6.09 M(+7.7%) |
| Mar 2018 | - | $1.76 M(+26.4%) | $5.65 M(+6.0%) |
| Dec 2017 | $5.33 M(+9.9%) | $1.39 M(+13.6%) | $5.33 M(+6.0%) |
| Sept 2017 | - | $1.23 M(-3.2%) | $5.03 M(+1.4%) |
| June 2017 | - | $1.27 M(-12.1%) | $4.96 M(+1.2%) |
| Mar 2017 | - | $1.44 M(+32.2%) | $4.90 M(+1.0%) |
| Dec 2016 | $4.85 M(-3.6%) | $1.09 M(-6.0%) | $4.85 M(-6.0%) |
| Sept 2016 | - | $1.16 M(-3.9%) | $5.16 M(-10.7%) |
| June 2016 | - | $1.21 M(-13.2%) | $5.78 M(-5.2%) |
| Mar 2016 | - | $1.39 M(-0.8%) | $6.10 M(+21.2%) |
| Dec 2015 | $5.03 M(+304.0%) | $1.40 M(-21.3%) | $5.03 M(+31.0%) |
| Sept 2015 | - | $1.78 M(+16.7%) | $3.84 M(+58.7%) |
| June 2015 | - | $1.53 M(+373.8%) | $2.42 M(+71.9%) |
| Mar 2015 | - | $322.10 K(+52.8%) | $1.41 M(+13.0%) |
| Dec 2014 | $1.24 M(+1290.9%) | $210.80 K(-41.5%) | $1.24 M(+20.4%) |
| Sept 2014 | - | $360.40 K(-29.9%) | $1.03 M(+53.5%) |
| June 2014 | - | $514.00 K(+221.9%) | $673.70 K(+288.7%) |
| Mar 2014 | - | $159.70 K(+1074.3%) | $173.30 K(+204.0%) |
| Dec 2013 | $89.50 K | - | - |
| June 2013 | - | $13.60 K(+423.1%) | $57.00 K(+31.3%) |
| Mar 2013 | - | $2600.00(-93.6%) | $43.40 K(+6.4%) |
| Dec 2012 | - | $40.80 K | $40.80 K |
FAQ
- What is Viking Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Viking Therapeutics?
- What is Viking Therapeutics annual SG&A year-on-year change?
- What is Viking Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Viking Therapeutics?
- What is Viking Therapeutics quarterly SG&A year-on-year change?
- What is Viking Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Viking Therapeutics?
- What is Viking Therapeutics TTM SG&A year-on-year change?
What is Viking Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of VKTX is $37.02 M
What is the all time high annual SG&A for Viking Therapeutics?
Viking Therapeutics all-time high annual selling, general & administrative expenses is $37.02 M
What is Viking Therapeutics annual SG&A year-on-year change?
Over the past year, VKTX annual selling, general & administrative expenses has changed by +$20.90 M (+129.64%)
What is Viking Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of VKTX is $13.77 M
What is the all time high quarterly SG&A for Viking Therapeutics?
Viking Therapeutics all-time high quarterly selling, general & administrative expenses is $13.77 M
What is Viking Therapeutics quarterly SG&A year-on-year change?
Over the past year, VKTX quarterly selling, general & administrative expenses has changed by +$4.88 M (+54.97%)
What is Viking Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of VKTX is -$1.66 B
What is the all time high TTM SG&A for Viking Therapeutics?
Viking Therapeutics all-time high TTM selling, general & administrative expenses is $42.81 M
What is Viking Therapeutics TTM SG&A year-on-year change?
Over the past year, VKTX TTM selling, general & administrative expenses has changed by -$1.70 B (-5242.64%)